Updates are available Correction dated 2019-08-27
Click to view Correction: https://doi.org/10.1038/s41551-019-0456-6
-
Authors
Moreno, Ana M.
Palmer, Nathan http://orcid.org/0000-0001-6347-9379
Alemán, Fernando
Chen, Genghao
Pla, Andrew
Jiang, Ning
Leong Chew, Wei http://orcid.org/0000-0002-4774-7959
Law, Mansun
Mali, Prashant http://orcid.org/0000-0002-3383-1287
- License Information
-
More Information
Article History
Received: 27 January 2018
Accepted: 16 June 2019
First Online: 22 July 2019
Change Date: 27 August 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: A.M.M., N.P. and P.M. have filed patents on the basis of this research. P.M. is a scientific co-founder of Navega Therapeutics, Pretzel Therapeutics, Seven Therapeutics, Engine Biosciences and Shape Therapeutics. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its policies regarding conflicts of interest. W.L.C. is a scientific co-founder of Seven Therapeutics. N.J. is a scientific advisor of ImmuDX, LLC and Immune Arch, Inc.
